Endvidere sås signifikante stigninger i hofte- BMD efter 18 måneders behandling på henholdsvis 1, 0; 1, 8 og 1, 0% (total, lårbenshals, trochanter) mod ÷1, 1; ÷0, 7 og ÷0, 6% for placebo (p < 0, 001).
Significant increases in hip BMD (total, femoral neck, trochanter) were observed at study endpoint; 1.0, 1.8 and 1.0%, respectively, for Preotact versus -1.1, -0. 7 and -0.6% for placebo (p < 0.001).